These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10855642)

  • 1. Kinetics of a putative hypoxic tracer, 99mTc-HL91, in normoxic, hypoxic, ischemic, and stunned myocardium.
    Imahashi K; Morishita K; Kusuoka H; Yamamichi Y; Hasegawa S; Hashimoto K; Shirakami Y; Kato-Azuma M; Nishimura T
    J Nucl Med; 2000 Jun; 41(6):1102-7. PubMed ID: 10855642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium.
    Kusuoka H; Hashimoto K; Fukuchi K; Nishimura T
    J Nucl Med; 1994 Aug; 35(8):1371-6. PubMed ID: 8046496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of reperfused myocardium using a new ischaemia-avid imaging agent, technetium-99m HL91: comparison with myocardial glucose uptake.
    Fukuchi K; Kusuoka H; Yutani K; Hasegawa S; Nishimura T
    Eur J Nucl Med; 1998 Apr; 25(4):361-6. PubMed ID: 9553165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent.
    Okada RD; Johnson G; Nguyen KN; Edwards B; Archer CM; Kelly JD
    Circulation; 1997 Apr; 95(7):1892-9. PubMed ID: 9107178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HL-91-technetium-99m: a new marker of viability in ischemic myocardium.
    Okada RD; Johnson G; Nguyen KN; Carlson LR; Beju D
    J Nucl Cardiol; 1999; 6(3):306-15. PubMed ID: 10385186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biodistribution of hypoxic marker, 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime)].
    Suzuki T; Nakamura K; Kawase T; Kubo A
    Kaku Igaku; 2001 Jul; 38(4):333-41. PubMed ID: 11530380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia.
    Ng CK; Sinusas AJ; Zaret BL; Soufer R
    Circulation; 1995 Sep; 92(5):1261-8. PubMed ID: 7648674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of response to radiation therapy for human tumor xenografts using 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime).
    Suzuki T; Nakamura K; Kawase T; Kubo A
    Ann Nucl Med; 2003 Apr; 17(2):131-8. PubMed ID: 12790362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia.
    Yutani K; Kusuoka H; Fukuchi K; Tatsumi M; Nishimura T
    J Nucl Med; 1999 May; 40(5):854-61. PubMed ID: 10319761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of ischemic myocardium with a new hypoxic tissue targeting tracer 99Tc(m)-HL91.
    Lü J; Liu G; Fang Y; Wu H
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):281-3, 291. PubMed ID: 16961269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tc-99m-HL91 imaging in the early detection of neuronal injury in a neonatal rat model of hypoxic ischemia.
    Lee BF; Wang LW; Lin SH; Jhuo TJ; Chiu NT; Huang CC; Hsia CC; Shen LH
    Crit Care Med; 2012 Jun; 40(6):1930-8. PubMed ID: 22610194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
    Honess DJ; Hill SA; Collingridge DR; Edwards B; Brauers G; Powell NA; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):731-5. PubMed ID: 9845086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-HL91 "hot spot" imaging of mice bearing human carcinoma by gamma camera and the effects of tumor necrosis on imaging.
    Yao Z; Qu W; Zhou Y; Zhu M; Zhu L
    Chin Med J (Engl); 2000 May; 113(5):404-7. PubMed ID: 11776093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.
    Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Pak KY; Okada RD
    J Nucl Cardiol; 2003; 10(2):168-76. PubMed ID: 12673182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-HL91: "hot spot" detection of ischemic myocardium in vivo by gamma camera imaging.
    Okada RD; Johnson G; Nguyen KN; Liu Z; Edwards B; Archer CM; North TL; King AC; Kelly JD
    Circulation; 1998 Jun; 97(25):2557-66. PubMed ID: 9657477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of Tc-99m HL91 in tumor hypoxia: in vitro cell culture and in vivo tumor model.
    Lee BF; Chiu NT; Hsia CC; Shen LH
    Kaohsiung J Med Sci; 2008 Sep; 24(9):461-72. PubMed ID: 19073378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium 99m-Q12 kinetics in perfused rat myocardium: effects of hypoxia and low flow.
    Okada RD; Nguyen KN; Lauinger M; Allton IL; Johnson G
    Am Heart J; 1996 Jul; 132(1 Pt 1):108-15. PubMed ID: 8701850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of 9mTc-HL91 SPECT hypoxia imaging in patients with advanced NSCLC].
    Li L; Yu JM; Sun XD; Zhu H; Yue JB; Sun CJ; Yang GR
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):127-30. PubMed ID: 17645850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
    Lewis JS; Herrero P; Sharp TL; Engelbach JA; Fujibayashi Y; Laforest R; Kovacs A; Gropler RJ; Welch MJ
    J Nucl Med; 2002 Nov; 43(11):1557-69. PubMed ID: 12411560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of graded hypoxia on retention of technetium-99m-nitroheterocycle in perfused rat heart.
    Rumsey WL; Patel B; Linder KE
    J Nucl Med; 1995 Apr; 36(4):632-6. PubMed ID: 7699458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.